Chromatin modifications, especially histone-tail acetylation, have been implicated in memory formation. Increased histone-tail acetylation induced by inhibitors of histone deacetylases (HDACis) facilitates learning and memory in wild-type mice as well as in mouse models of neurodegeneration. Harnessing the therapeutic potential of HDACis requires knowledge of the specific HDAC family member(s) linked to cognitive enhancement. Here we show that neuron-specific overexpression of HDAC2, but not that of HDAC1, decreased dendritic spine density, synapse number, synaptic plasticity and memory formation. Conversely, Hdac2 deficiency resulted in increased synapse number and memory facilitation, similar to chronic treatment with HDACis in mice. Notably, reduced synapse number and learning impairment of HDAC2-overexpressing mice were ameliorated by chronic treatment with HDACis. Correspondingly, treatment with HDACis failed to further facilitate memory formation in Hdac2-deficient mice. Furthermore, analysis of promoter occupancy revealed an association of HDAC2 with the promoters of genes implicated in synaptic plasticity and memory formation. Taken together, our results suggest that HDAC2 functions in modulating synaptic plasticity and long-lasting changes of neural circuits, which in turn negatively regulates learning and memory. These observations encourage the development and testing of HDAC2-selective inhibitors for human diseases associated with memory impairment.
Neuronal adaptive responses implicated in memory formation and storage involve functional and structural synaptic changes, which require alterations in gene expression 1, 2 . The mechanisms underlying this process are still unclear. Chromatin remodelling, especially through histone-tail acetylation, which alters the compact chromatin structure and changes the accessibility of DNA to regulatory proteins, is emerging as a fundamental mechanism for regulating gene expression 3, 4 . Recently, histone acetylation has been implicated in synaptic plasticity and learning behaviour [5] [6] [7] [8] [9] . In particular, it was shown that the non-selective HDAC inhibitor sodium butyrate reinstated learning ability and promoted the retrieval of long-term memory in mice even after massive neuronal loss 10 . Taken together, these observations indicate that HDAC inhibition may provide a therapeutic avenue for memory impairment caused by neurodegenerative and other diseases. However, the clinical application of broadly acting non-selective HDACis in cancer has shown a range of untoward effects, which may limit their utility in application to non-lethal, chronic diseases [11] [12] [13] . Thus, identification of the HDAC family member(s) specifically involved in memory formation will help in discovering the mechanism(s) by which chromatin remodelling regulates memory and lead to more selective HDACis for memory enhancement.
Chronic HDACi treatment facilitates memory formation
On the basis of HDAC selectivity studies in vitro, sodium butyrate might affect brain function mainly through class I HDACs, including Hdac1, Hdac2, Hdac3 and Hdac8 (Supplementary Information). To gain further insight into the ability of systemic HDACis to enhance memory, and to identify more potent HDACis than sodium butyrate 10 , a set of prototypical HDACis with a wide range of structures and metal-chelating elements were tested in mice using a contextual fear conditioning assay. While some HDACis did not facilitate memory formation (data not shown), chronic treatment with suberoylanilide hydroxamic acid (SAHA; vorinostat), a clinically approved agent, enhanced memory formation more potently than sodium butyrate ( Supplementary Figs 1 and 16c, d ). This finding is consistent with the previous report 5 that SAHA rescued memory deficits in a mouse model of Rubinstein-Taybi syndrome. Given the ability of both compounds to cross the blood-brain barrier, as measured indirectly by changes in histone acetylation in brain 10, 14, 15 and directly by measuring the amount of SAHA in the brain (data not shown), we focused our subsequent studies on SAHA-induced memory enhancement.
Because SAHA inhibits primarily class I HDACs and HDAC6 (ref. 16 ), a class II HDAC known to target acetylation of a-tubulin on Lys 40 (a-tubulin(K40)) 17, 18 , we examined whether selective inhibition of HDAC6 with the HDACi WT-161 had effects on memory formation ( Supplementary Fig. 2a-c) . WT-161 did not increase memory formation ( Supplementary Fig. 2d ), suggesting that HDAC6 inhibition is not responsible for SAHA-induced memory enhancement. In agreement with these observations, proteome-wide studies of a SAHA-based affinity probe indentified HDAC1 and HDAC2 as the main cellular targets 19 , indicating that these may be relevant targets for HDACi-induced memory enhancement.
Hdac2, but not Hdac1, functions in memory formation To directly evaluate the physiological role of HDAC1 and HDAC2 in the brain, we generated two mouse lines in which HDAC1 or HDAC2 was overexpressed in neurons ( Supplementary Fig. 3a-c ). The mouse Hdac1 or Hdac2 coding sequence was placed in frame with the endogenous initiation codon of exon 1 of the Tau (also known as Mapt) gene, thereby creating a fusion protein containing the first 31 amino-acid residues of Tau. Previously, homozygous animals mutant for Tau were shown to be indistinguishable from wild-type littermates in memory tests 20, 21 . A two-to threefold increase in HDAC1 or HDAC2 protein expression in brain of homozygous animals in comparison with wildtype mice was observed in the hippocampus and other areas of the brain ( Fig. 1a and Supplementary Fig. 4 ). Consistently, the overall level of acetylated lysine was decreased in homozygous HDAC1-overexpressing (HDAC1OE) and HDAC2-overexpressing (HDAC2OE) mice ( Fig. 1b) , especially in the pyramidal neurons of the hippocampal formation ( Supplementary Fig. 3d ). We found decreased acetylation of histone 4 on Lys 12 (H4K12) and H4K5, but not of H3K14, in HDAC2OE mouse brains ( Fig. 1b and data not shown). In contrast, the level of acetylated a-tubulin(K40) did not change in HDAC1OE or HDAC2OE mice. Thus, the HDAC1/2-overexpressing animals showed increased histone deacetylation in the brain in comparison with wild-type littermates. There was no discernible difference in gross brain anatomy or neuronal positioning in the HDAC1/2-overexpressing mice (Supplementary Figs 5 and 12), suggesting that increased HDAC1/2 is not detrimental to brain development.
To evaluate the consequence of HDAC1/2 overexpression on hippocampus-dependent memory formation, four-month-old HDAC1OE and HDAC2OE mice were trained using Pavlovian fear conditioning paradigm before a memory test 24 h later. Whereas HDAC1OE mice (n 5 17) displayed a comparable freezing level (P 5 0.6470, context; P 5 0.8199, tone) to that of the control mice (n 5 19), we found that HDAC2OE mice (n 5 14) showed markedly decreased freezing behaviour in both context-dependent and tonedependent fear learning ( Fig. 1c , P 5 0.0035 and P 5 0.0007, respectively). The decrease in freezing behaviour in HDAC2OE mice was not due to motor defects or impaired pain sensation, because their response to electric foot shock and the explorative behaviour during exposure to novel context were similar to those of the control mice ( Fig. 1d, e ). In the short-term memory test, no significant difference could be detected between HDAC1OE, HDAC2OE and wild-type control mice in both context-dependent and tone-dependent fear learning 3 h after training ( Supplementary Fig. 6b ). These observations suggest that a gain of HDAC2 function (but not that of HDAC1) in the nervous system results in associative learning impairments.
To evaluate the integrity of hippocampus-dependent memory formation in the HDAC2OE mice further, we used the Morris water maze paradigm. The escape latency of the HDAC1OE mice closely paralleled that of the control mice during a 9-day training period for the hidden-platform model (P 5 0.7784, two-way analysis of variance (ANOVA)). In contrast, the HDAC2OE mice showed significantly increased escape latency throughout the training process (P 5 0.0010, two-way ANOVA; Fig. 1f ). A probe trial was also performed to quantitatively measure the time spent in each quadrant of the swimming pool when the hidden platform was removed from the pool. Notably, the HDAC2OE mice did not show a preference for the target quadrant, whereas the control mice (P 5 0.0145, target quadrant versus opposite quadrant) and HDAC1OE mice (P 5 0.008) spent significantly more time in the target quadrant ( Fig. 1g ). Comparable motor and visual function between the various strains were observed in the visible-platform test ( Supplementary Fig. 6a, b) . These results revealed a marked decrease in spatial learning of the HDAC2OE mice. Furthermore, HDAC2OE (but not HDAC1OE) mice showed impairment of spatial working memory in a T-maze non-matching-to-place task ( Supplementary Fig. 6h ). Thus, a gain of HDAC2 function, but not that of HDAC1, impairs hippocampusdependent memory formation as well as working memory.
To further investigate the role of HDAC2 in associative learning, Hdac2-deficient mice (HDAC2KO) were generated by crossing mice carrying a floxed Hdac2 allele with Nestin-Cre transgenic mice. Germline deletion of Hdac2 resulted in viable and fertile Hdac2 1/2 mice with no obvious histological abnormalities up to a year of age (Supplementary Methods and Supplementary Fig. 7 ). Crossing Hdac2 1/2 mice gave rise to viable Hdac2-deficient mice, which had normal brain anatomy and cell positioning ( Fig. 2a H2B acetylation were significantly increased in the hippocampus of HDAC2KO mice. However, overall lysine acetylation in histone preparations was slightly decreased, as revealed by western blot analysis ( Fig. 2b ). This might be the consequence of a compensatory increase in HDAC1 in HDAC2KO mice ( Supplementary Fig. 7d ). The HDAC2KO mice showed markedly increased freezing behaviour as evaluated by the context-dependent and tone-dependent fear conditioning model (P 5 0.0036, P 5 0.0047; Fig. 2c ) 24 h after training in comparison with wild-type littermates. In the short-term memory test, HDAC2KO mice showed increased freezing behaviour (P 5 0.010; Supplementary Fig. 6e ) in comparison with wild-type littermates in context-dependent conditioning. No differences in the locomotor activity or pain sensation were detected between these two groups of mice ( Fig. 2d, e ). Thus, loss of HDAC2 function enhanced associative learning. Furthermore, HDAC2KO mice showed a profound spatial working memory improvement in the T-maze nonmatching-to-place task (P 5 0.025, two-way ANOVA; Supplementary  Fig. 6g ). These data, coupled with the gain-of-function studies, suggest that HDAC2 negatively regulates memory formation in mice.
HDAC2 regulates synaptogenesis and synaptic plasticity
Because the synapse is widely assumed to be the cellular basis for learning and memory 22 , we assessed whether HDAC2 regulates the density of dendritic spines and therefore synapse numbers. Indeed, the density of dendritic spines along individual dendrites of hippocampal CA1 pyramidal neurons and dentate gyrus (DG) granule cells was markedly decreased in HDAC2OE mice (P , 0.005; Fig. 3a and Supplementary Fig. 15a, b ), but not in HDAC1OE mice (Supplementary Fig. 9a ), in comparison with wild-type mice. Conversely, spine density was significantly higher in HDAC2KO mice, suggesting that HDAC2 suppresses spine formation in hippocampal CA1 and DG neurons. Detailed quantifications showed that spine shape is not related to the expression level of HDAC2 ( Supplementary Fig. 15a, b ). Furthermore, immunoreactivity towards synaptophysin 10 , which labels presynaptic terminals of functional synapses, was significantly increased in the CA1 striatum radiatum of the HDAC2KO mice (P , 0.0001) and decreased in HDAC2OE mice in comparison with wild-type mice (P 5 0.0279; Fig. 3b ), indicating more presynaptic terminals in HDAC2KO mice and fewer in HDAC2OE mice. The pattern of change in synaptophysin staining in the amygdala was similar to that observed in area CA1 ( Supplementary Fig. 8b ). Taken together, these results suggest that HDAC2 regulates synapse formation. We next determined whether HDAC2 also regulates synaptic plasticity. To this end, we performed electrophysiological recordings on hippocampal slices prepared from HDAC2OE mice, HDAC2KO mice and their control littermates. Long-term potentiation (LTP) of CA1 neurons induced by two trains of high-frequency stimulation (HFS) on the Schaffer collaterals was observed in wild-type but impaired in HDAC2OE mice ( Fig. 3c ). A single train of HFS induced synaptic potentiation of WT CA1 neurons, which rapidly decayed, whereas robust LTP was readily induced by one train of HFS in CA1 neurons of HDAC2KO mice ( Fig. 3d ). No significant difference between wildtype and HDAC2OE groups was observed in paired-pulse facilitation (data not shown). As an additional control, we found that hippocampal LTP was not altered in HDAC1OE in comparison with wild-type controls ( Supplementary Fig. 9c ). Thus, overexpression of HDAC2 impaired synaptic plasticity, whereas loss of HDAC2 function facilitates synaptic plasticity. Taken together, these data indicate an inverse relationship between levels of HDAC2 and synapse numbers, which in turn affects synaptic plasticity and learning and memory.
HDAC2 suppresses neuronal gene expression
It was previously suggested that HDACs regulate learning and memory by repressing gene expression through chromatin remodelling 5,7,9 . Specifically, HDACis were reported to enhance memory formation Yellow arrowheads indicate the spines. KO, HDAC2KO; OE, HDAC2OE. Scale bar, 10 mm. b, Representative confocal images of synaptophysin (SVP)immunoreactive (IR) signal on CA1 (HDAC2KO, n 5 17; WT, n 5 25; HDAC2OE, n 5 21). py, pyramidal neuron layer; s.r., stratum radiatum. Scale bar, 50 mm. *P , 0.05; **P , 0.005; ***P , 0.001. c, LTP was induced by two trains of HFS (2 3 100 Hz, 1 s) in the CA1 region from six-month-old HDAC2OE mice (red trace; n 5 8) or their WT littermates (black trace; n 5 7). By 40 min, the field excitatory postsynaptic potentials (fEPSPs) from HDAC2OE mice decayed to the baseline (103.1 6 1.8% compared with baseline), whereas fEPSPs from control mice remained potentiated (137.9 6 6.8% compared with the baseline). d, LTP was induced by one HFS in the CA1 region from HDAC2KO mice (red trace; n 5 8) or their WT littermates (black trace; n 5 6). Slices from WT mice showed a transient potentiation that decayed to the baseline (102.9 6 4.5% compared with the baseline), 40 min after induction, whereas slices from HDAC2KO mice showed a robust potentiation (144.1 6 2.0% compared with the baseline). and synaptic plasticity through CREB-CBP-dependent transcriptional activation 9 . We speculated that HDAC2 might suppress the expression of memory-associated genes by binding to their regulatory elements. We surveyed the association of HDAC1 or HDAC2 with the promoter of a total of 24 genes implicated in synaptic remodelling/plasticity or regulated by neuronal activity ( Supplementary Table 1 ), and other genes that are not specifically associated with synaptic function. To this end, we performed chromatin immunoprecipitation (ChIP). Consistent with previous reports that both HDAC1 and HDAC2 are associated with cell cycle genes, we observed a similar enrichment of HDAC1 and HDAC2 at the promoters of p21 (also known as Cdkn1a), Atf4 and Pgk1 (Fig. 4a) . In contrast, with minor exceptions, HDAC2 was more enriched than HDAC1 at the promoters of genes implicated in synaptic remodelling/plasticity or regulated by neuronal activity, including Bdnf promoter I/II, Egr1, Fos, Cpg15 (also known as Nrn1), Camk2a, Creb1, Crebbp, NRXN3 and the NMDA receptor subunits ( Fig. 4a and Supplementary Fig. 10b ). HDAC2 antibody failed to enrich these promoter sequences in preparations made from HDAC2KO brain ( Supplementary Fig. 10a ), demonstrating the specificity of the previous results. Furthermore, we determined that levels of AcH3 and AcH4 were increased in multiple synaptic plasticity genes including Bdnf-pII, Egr1, Fos and GLUR1 (also known as Gria1) promoters in the HDAC2KO mice in comparison with the wild-type controls (Fig. 4b) . A significant decrease in AcH3 in Bdnf-pII, Fos and Gria1 promoters was also detected in HDAC2OE mice, but not in HDAC1OE. Consistent with the notion that HDAC2 negatively regulates gene expression, the protein levels of multiple synaptic genes were markedly increased in the brain of HDAC2KO mice and decreased in HDAC2OE mice but not in HDAC1OE mice (Supplementary Figs 10c, d and 11a, b ). Furthermore, in dissociated neurons, treatments with forskolin, KCl or BDNF (brain-derived neurotrophic factor), all of which activate the CREB pathway 23 , increased EGR1 expression in an EGR1-GFP reporter assay ( Supplementary Figs  11c, d and 16a, b) . SAHA treatment markedly potentiated the expression of EGR1-GFP, which is consistent with the notion that HDAC2 inhibition allows greater activation of the CREB-CBP pathway because 
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Psd95 Agrin N r x n 1 N r x n 3 S V P S h a n k 3 S y n a p s i n 2 P s d 9 5 A g r i n EGR1 is a known CREB target gene. In these neurons, the effect of treatment with SAHA alone was not as potent as simultaneous treatment with either forskolin or KCl. Taken together, these experiments suggest that HDAC2 suppresses the expression of synaptic remodelling and plasticity genes. Thus, changes in expression of these genes in HDAC2KO and HDAC2OE mice might underlie the facilitated or impaired learning behaviour and synaptic plasticity of these mice.
CoREST associates with HDAC2 in the brain In an attempt to decipher the mechanism by which HDAC2, but not HDAC1, preferentially occupies activity-dependent gene promoters in vivo, we investigated the distribution of HDAC1 and HDAC2 in the brain and the association of these two HDACs with co-repressors. We found that HDAC2 was expressed more abundantly in neurons whereas HDAC1 was expressed more robustly in the cells positive for GFAP (glial fibrillary acidic protein; Supplementary Fig. 14a, b ). When we evaluated the associations of HDAC1 and HDAC2 with mSin3a, CoREST and MTA2 (NuRD) in wild-type and HDAC2KO brains, we observed interactions of HDAC2 with all three co-repressors (Fig. 4c) .
In contrast, we failed to detect an association of HDAC1 with CoREST in wild-type mice and even in HDAC2KO brain lysates, despite the fact that HDAC1 was upregulated and its association with mSin3a and MTA2 was higher in these brains (Fig. 4c) . These experiments suggest that CoREST preferentially associates with HDAC2. CoREST has been shown to have a key function in repressing neuronal gene expression by recruiting the molecular machinery responsible for silencing across a chromosomal interval 24, 25 . Thus, our finding that HDAC2, but not HDAC1, interacts with CoREST in the brain fits in well with the notion that loss of HDAC2 function in neurons leads to the upregulation of neuronal genes involved in basal and activity-induced neuronal functions that facilitate learning and memory. Our results are also consistent with the recent report that alteration of S-nitrosylation of HDAC2 alone could affect EGR1/c-Fos expression in neurons 26 .
HDACis elicit memory enhancement through HDAC2
The enhanced learning and memory, facilitated synaptic plasticity, and increased dendritic spine density and synapse number in the HDAC2KO mice are highly reminiscent of the reported effects of treatment with HDACis 5,7,10 . We wondered whether HDAC2 is the major target for HDACi-induced memory enhancement. If this were so, one would expect that the learning impairment of HDAC2OE mice would be readily ameliorated by treatment with HDACis, whereas the same treatment should have no effect on memory formation in HDAC2KO mice. Because SAHA was found to be a more potent memory enhancer than sodium butyrate when given to mice ( Supplementary Fig. 1c ), we used SAHA in all subsequent experiments. SAHA was administered daily by intraperitoneal injection (25 mg kg 21 ) for 10 days before contextual fear conditioning training and memory testing. Notably, SAHA significantly increased the freezing behaviour of HDAC2OE mice, from 26.9 6 5.9% to 66.7 6 5.1% (means 6 s.e.m. throughout; Fig. 5a ). It should be noted that in the same training models, SAHA treatment increased the freezing behaviour of wild-type control mice from 44.8 6 4.7% to 63.9 6 4.2%. Thus, the freezing levels of HDAC2OE mice after SAHA treatment were comparable to those of the control mice treated with SAHA, despite the fact that saline-treated HDAC2OE mice showed lower freezing behaviour. Concordantly, SAHA treatment completely abrogated the decreased dendritic spine and synapses phenotype in HDAC2OE mice (Fig. 5b,c) . Next we investigated the effects of SAHA on HDAC2KO mice. Because HDAC2KO mice showed markedly increased freezing behaviour in comparison with wild-type littermates without treatment, we sensitized the assay by lowering the foot shock intensity from 1.0 to 0.5 mA to prevent a possible ceiling effect. In this model, SAHA treatment induced significantly higher freezing behaviour (P 5 0.0383) in the wild-type control mice (45.0 6 6.9% versus 25.0 6 5.8%; Fig. 5d ). However, SAHA treatment did not alter the freezing behaviour in the HDAC2KO mice (52.1 6 9.8% versus 49.3 6 8.4%, P 5 0.8324; Fig. 5d ). Furthermore, dendritic spine density of CA1 neurons and synaptophysin staining in the stratum radiatum of the HDAC2KO mice were not significantly affected by SAHA treatment (Fig. 5e, f) . Consistently, although SAHA treatment modestly increased LTP in the wild-type hippocampus, it did not have a detectable effect on LTP in the HDAC2KO hippocampus ( Supplementary Fig. 13 ). Thus, HDAC2KO mice are refractory to synaptogenesis and to facilitation of synaptic plasticity and memory formation induced by SAHA. These results strongly suggest that HDAC2 is the major, if not the only, target of SAHA in eliciting memory enhancement.
Discussion
Using mouse genetic models, we delineated the functions of HDAC1 and HDAC2 in the brain, and showed evidence that HDAC2 has a negative function in regulating memory formation. Notably, we identified HDAC2 as the major target of HDACi for facilitating learning and memory. However, we cannot rule out the possibility that other HDAC family members also have a role in synaptic function and memory, or that non-histone substrates may also be modulated by HDAC2. Our observations suggest that HDAC1 and HDAC2 differentially regulate subsets of activity-regulated genes implicated in plasticity and memory. This is unexpected, given that HDAC1 and HDAC2 were reported to form functional heterodimers 27 . However, here we have shown that, HDAC2 is more abundant than HDAC1 in the corepressor complexes containing CoREST and that HDAC2 is expressed more abundantly in neurons, providing further insight into the functional differences between HDAC1 and HDAC2 in the nervous system. Other possibilities, such as differences in post-translational modifications, might also contribute to the biochemical and functional dissociation between HDAC1 and HDAC2, because HDAC2 has recently been shown to be modified by S-nitrosylation and to regulate EGR1 expression 26 . It should be noted that Hdac1 deficiency in mice is detrimental, resulting in embryonic lethality 28 . A recent study has indicated that loss of HDAC1 function in neurons causes DNA damage and cell death 29 . Conversely, Hdac2-deficient mice are viable and have enhanced memory formation. Using genetic models, we have found a new and unexpected function of HDAC2 as a repressor of synaptic plasticity genes and as a mediator of the beneficial effects of HDACis. Not only do these results reveal important distinct functions of HDAC1 and HDAC2 in adult mouse brain, they also suggest a new strategy for therapeutic intervention of human diseases associated with memory impairment.
METHODS SUMMARY
The mouse HDAC1 or HDAC2 coding sequence was placed into exon 1 of the Tau gene. HDAC2KO mice were produced in the laboratory of R.A.D. and engineered to contain loxP recombination sites such that Cre-mediated recombination deleted exons 5 and 6. Sodium butyrate (Sigma) was dissolved in saline. HDAC inhibitors were dissolved in dimethylsulphoxide (DMSO) at 50 mg ml 21 and diluted with saline immediately before injection (100-150 ml, intraperitoneally). Lysates for immunoblotting were prepared as described previously 4 . Immunoblot data were quantified by measuring the band intensity with NIH imaging software and UN-SCAN-it gel digitizing software (Silk Scientific). Immunostaining was performed as described previously 4 with LSMeta10 software and a confocal microscope (Zeiss). All behavioural testing was performed as described previously 4 . The data were analysed by unpaired Student's t-test. Two-way ANOVA was used to compare difference between groups at several time points.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
METHODS
Gene targeting construct for HDAC1OE mice. The ,1,200-nucleotide-long mouse HDAC1 complementary DNA was amplified from a brain cDNA library and confirmed by sequencing. The cDNA was then cloned upstream of the polyadenylation (pA) signal of pC8N2 with a SpeI blunt ligation; subsequently HDAC1-pA was cloned into pBSK (Stratagene). A pGKneoLoxP sequence was directionally inserted into the XhoI-Kpn1 site downstream of HDAC1-pA in pBSK. HDAC1-pA-neo was released with XmaI-Acc65 and cloned in frame into exon 1 of the Mapt gene. The Mapt targeting arms were taken from pTauKR 21 and modified by the insertion of an XmaI and BsiWI linker in the unique NcoI site. The resulting targeting vector (pTH1) containing the in-frame fusion of the HDAC1 coding sequence with exon 1 of Mapt was confirmed by sequencing. Mice 3-6 months old were used for the behaviour test and further analysis. Gene targeting construct for HDAC2OE mice. The mouse HDAC2 cDNA was obtained by RT-PCR from mouse brain tissue. It was sequenced and subcloned into the XhoI-EcoR1 site of the Topo-TA vector (Invitrogen). The pTH1 targeting vector (described above) was cut open with SmaI-SalI to release HDAC1. The HDAC2 cDNA was cut out from Topo-TA with EcoRI-XhoI and cloned into the SmaI-SalI site of pTH1, to create the pTH2 targeting vector. The inframe fusion of HDAC2 to exon 1 of Tau was verified by sequencing of pTH2. The targeting vectors pTH1 and pTH2 were linearized with SacI and electroporated into the V6.5 (129 3 C57BL/6) F 1 embryonic stem (ES) cell line. We picked 96 neomycin-resistant clones, of which 46 were analysed by Southern blots. We used only a 39 external probe, after digestion with BamHI and EcoRI. Wild-type clones show a band at 8.8 kilobases (kb). The correct targeting event results in a band shift to 13 kb for the targeted allele. Five clones were correctly targeted. Two clones were used to generate chimaeras by injections into (DBA/ 2 3 C57BL/6) F 1 blastocysts. Chimaeras were mated to C57BL/6 females and offspring were analysed for germline transmission. The heterozygous knock-in strains were maintained in a mixed background and were mated to obtain homozygous animals. Mice 3-6 months old were used for the behaviour test and further analysis. Generation of HDAC2KO mice. The Hdac2 floxed allele was generated by flanking exons 5 and 6 with loxP recombination sites, ensuring the deletion of the HDAC-catalytic core of the protein after Cre-recombinase-mediated deletion ( Supplementary Fig. 7a ). On successful targeting of ES cells and subsequent derivation of chimaeric mice, we established a mouse strain carrying a floxed allele of Hdac2 (Hdac2 L ) (FVB). Infection of mouse embryonic fibroblasts (MEFs) with retroviruses expressing Cre recombinase resulted in complete ablation of HDAC2 only in MEFs carrying two floxed Hdac2 alleles ( Supplementary  Fig. 7b ). This indicates that the floxed Hdac2 allele is functional and results in an Hdac2-null genotype on expression upon Cre recombinase. Deletion of Hdac2 in the germline with EIIa-Cre or Nestin-Cre transgenic mice resulted in viable and fertile Hdac2 1/2 mice with no obvious histological abnormalities up to one year of age. Crossing Hdac2 1/2 mice gave rise to viable Hdac2-deficient mice, but these mice were born with a twofold lower frequency than expected from a normal Mendelian ratio (9 Hdac2 2/2 mice out of 79 littermates, in contrast with 20 out of 79 expected; Supplementary Fig. 7c ). Although Hdac2 2/2 mice are viable and are capable of producing offspring, their fertility is compromised (data not shown). Hdac2 2/2 mice (males and females) were about 25% smaller than wild-type and heterozygote littermates (data not shown). The animals used for behaviour tests were in a FVB 3 C57/BL6 background and mated to each other to obtain homozygous animals. Mice 3-6 months old were used for the behaviour test and further analysis. There were no difference in behaviour test results between males and females. Fear conditioning tests. Context-dependent fear conditioning: training consisted of a 3-min exposure of mice to the conditioning box (context) followed by a foot shock (2 s; 0.5, 0.8 or 1.0 mA constant current). The memory test was performed 24 h later by re-exposing the mice for 3 min to the conditioning context. Freezing, defined as a lack of movement except for heartbeat and respiration associated with a crouching posture, was recorded every 10 s by two trained observers (one was unaware of the experimental conditions) for 3 min (a total of 18 sampling intervals). The number of observations indicating freezing obtained as a mean from both observers was expressed as a percentage of the total number of observations. For the short-term memory test, the memory test was performed 3 h after the foot-shock training.
Tone-dependent fear conditioning: training consisted of a 3-min exposure of mice to the conditioning box (context), followed by a tone (30 s, 20 kHz, 75 dB sound pressure level (SPL)) and a foot shock (2 s, 0.8 mA constant current) 30 . The memory test was performed 24 h later by exposing the mice for 3 min to a novel context followed by an additional 3-min exposure to a tone (10 kHz, 75 dB SPL). Freezing was recorded every 10 s by two unnbiased observers as described above.
Morris water maze test. The water maze model 31 was performed in a circular tank (diameter 1.8 m) filled with opaque water. A platform (11 cm 3 11 cm) was submerged below the water's surface in the centre of the target quadrant. The swimming path of the mice was recorded by a video camera and analysed by Videomot 2 software (TSE-Systems). For each training session, the mice were placed into the maze consecutively from four random points of the tank. Mice were allowed to search for the platform for 60 s. If the mice did not find the platform within 60 s, they were gently guided to it. Mice were allowed to remain on the platform for 15 s. Two training trials were given every day; the latency for each trial was recorded for analysis. During the memory test (probe test), the platform was removed from the tank, and the mice were allowed to swim in the maze for 60 s. Spatial working memory on elevated T-maze. Mice were maintained on a restricted feeding schedule at 85% of their free-feeding weight. Spatial working memory was first assessed on an elevated plastic T-maze. This consisted of a start arm (47 cm 3 10 cm) and two identical goal arms (35 cm 3 10 cm), surrounded by a wall 10 cm high. A plastic food well was located 3 cm from the end of each goal arm. The maze was located 1 m above the floor in a well-lit laboratory that contained various prominent distal cues beyond the maze. The mice were habituated to the maze and to drinking sweetened condensed milk, over several days before spatial non-matching-to-place testing.
Each trial consisted of a sample run and a choice run. On the sample run, the mice were forced either left or right by the presence of a plastic block, according to a pseudorandom sequence (with equal numbers of left and right turns per session, and with no more than two consecutive turns in the same direction). A reward consisting of 0.07 ml of sweetened condensed milk (diluted 1:1 with water) was available in the food well at the end of the arm. The block was then removed, and the mouse was placed, facing the experimenter, at the end of the start arm and allowed a free choice of either arm. The time interval between the sample run and the choice run was approximately 15 s. The animal was rewarded for choosing the previously unvisited arm (that is, for alternating). Mice were run one trial at a time with an intertrial interval of about 10 min. Each daily session consisted of 4 trials, and mice received 24 trials in total. Administration of chemicals. SAHA was synthesized as described previously in ref. 32 . WT-161 was synthesized by J.E.B. (details are available from the author). Sodium butyrate was purchased from Sigma (catalogue no. B5887). SAHA and WT-161 were dissolved in DMSO as stock solutions and diluted in saline just before injection. Sodium butyrate was prepared in saline. Mice received intraperitoneal injection daily with either SAHA or saline for either 10 or 21 days, using a vehicle consisting of 10% DMSO/90% saline (water containing 0.9% NaCl). SAHA and WT-161 solutions were first prepared by making a 50 mg ml 21 compound/DMSO stock solution, then diluted 1:9 with saline (5 mg ml 21 final concentration) so that the final volume of DMSO was 10%, and administered immediately with a 26-gauge needle. Golgi impregnation. Golgi-Cox-stained brains 33 were cut to cross-sections 200 mm thick with a Vibratome (Leica) and analysed with a Zeiss 200 Axiovert microscope and Openlab software. The number of apical and basal spines on hippocampal CA1 pyramidal neurons was counted blind to the genotype. For each experimental group, a minimum of ten cells per slice (animal number n 5 3) were analysed. CA1 hippocampal neurons within the region 21.4 mm to 21.6 mm (relative to the bregma position) were included for the analysis. Virus-mediated spine labelling. Tomato-expressing herpes simplex virus (HSV; 0.5 ml; a gift from R. Neve) was stereo-injected into both sides of area CA1 or dentate gyrus at a rate of 0.05 ml min 21 . Mice were killed 48 h after injection. Brains were fixed with 4% paraformaldehyde (PFA) and sectioned with a Vibratome (50-mm slices). Hippocampal slices were scanned with a confocal microscope. The image stacks obtained were reconstructed and analysed with Image J (NIH). Immunohistochemistry. Immunohistochemical analysis was performed as described previously 34 . Antibodies were used at a dilution of 1:1,000. Anti-HDAC1 and anti-HDAC2 antibodies were purchased from Abcam. Anti-Aclysine, anti-Ac-H4K5, anti-Ac-H4K12, anti-Ac-H3K16, anti-CREB, anti-AKT and anti-CaMKIIa antibodies were purchased from Cell Signaling. Anti-Ac-atubulin (K40), anti-actin and anti-synaptophysin (SVP-38) antibodies were purchased from Sigma. Anti-NR2A and anti-NR2B were purchased from BD Biosciences. Anti-b-catenin, anti-EGR1, anti-c-Fos, anti-Brn1, anti-TLE4, anti-CDP, anti-ER81 and anti-GAPDH antibodies were purchased from Santa Cruz. Anti-NeuN antibody was purchased from Chemicon. Confocal images (1 mm) were scanned and subjected to three-dimensional reconstruction. LSMeta10 software (Zeiss) was used to calculate the mean synaptophysin intensity. Brain sections with the strongest intensity were scanned first. All other images included in the analysis were scanned with the same settings. Staining was quantified with LSMeta10 software (Zeiss). Protein extraction and immunoblotting. The hippocampus and forebrain were collected and lysed in RIPA buffer. The lysates were incubated for 15 min on ice and centrifuged for 15 min at 15,000g and 4 uC. The supernatant was collected as
